SHERRI ZUMDIECK: Open Payments
NPI 1114966272 · BREMERTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 47 payments from 20 companies in 2025. Trend: 2023 $1,785 · 2024 $2,041 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $149 |
| AstraZeneca Pharmaceuticals LP | 5 | $124 |
| Lilly USA, LLC | 5 | $121 |
| ABBVIE INC. | 5 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| Amgen Inc. | 3 | $82 |
| Novo Nordisk Inc | 3 | $71 |
| Viatris Specialty LLC | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $40 |
Products named: JARDIANCE, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, REXULTI, BREZTRI, YUPELRI.
Industry payments across WA — which companies pay providers there.
